HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Syd Johnson Selected Research

Syd Johnson Research Topics

Disease

19Infections
01/2019 - 05/2005
8Neoplasms (Cancer)
01/2018 - 09/2007
6West Nile Fever
12/2011 - 05/2005
3Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 05/2015
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2018 - 10/2006
3Flavivirus Infections
11/2011 - 12/2007
3Severe Dengue
02/2010 - 12/2007
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016 - 05/2015
2Thrombocytopenia (Thrombopenia)
09/2015 - 02/2010
2Body Weight (Weight, Body)
04/2015 - 06/2010
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2013 - 08/2011
2Dengue (Dengue Fever)
02/2013 - 02/2010
2Autoimmune Diseases (Autoimmune Disease)
01/2012 - 09/2007
2Hypersensitivity (Allergy)
01/2012 - 07/2007
2Virus Diseases (Viral Diseases)
09/2010 - 12/2007
1Colorectal Neoplasms (Colorectal Cancer)
01/2018
1Colonic Neoplasms (Colon Cancer)
01/2018
1Lymphoma (Lymphomas)
01/2018
1Leukemia
01/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1Cytokine Release Syndrome
09/2015
1Arthritis (Polyarthritis)
08/2014
1Exanthema (Rash)
08/2011
1Anthrax
06/2011
1Edema (Dropsy)
06/2011
1Breast Neoplasms (Breast Cancer)
01/2011
1Burkitt Lymphoma (Burkitt's Lymphoma)
06/2010
1Viremia
02/2010
1Emerging Communicable Diseases (Emerging Infectious Diseases)
02/2010
1Paralysis (Palsy)
04/2008
1acute flaccid myelitis
04/2008
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2007
1Respiratory Syncytial Virus Infections
05/2007
1Encephalitis (Encephalitis, Rasmussen)
11/2006

Drug/Important Bio-Agent (IBA)

20Monoclonal AntibodiesIBA
01/2019 - 05/2005
12AntibodiesIBA
01/2016 - 05/2005
6Proteins (Proteins, Gene)FDA Link
01/2018 - 11/2006
5AntigensIBA
01/2018 - 06/2010
4Bispecific AntibodiesIBA
01/2018 - 06/2010
3VaccinesIBA
02/2013 - 09/2010
3EpitopesIBA
12/2011 - 05/2005
3Immunoglobulin G (IgG)IBA
11/2009 - 12/2007
2CytokinesIBA
01/2018 - 02/2010
2Glycoproteins (Glycoprotein)IBA
01/2018 - 09/2005
2teplizumabIBA
11/2013 - 08/2011
2Complement System Proteins (Complement)IBA
11/2011 - 12/2007
1PerforinIBA
01/2018
1Granzymes (Granzyme)IBA
01/2018
1PF-06671008IBA
03/2016
1Cadherins (E-Cadherin)IBA
03/2016
1InterleukinsIBA
01/2016
1Interleukin-3 Receptor alpha SubunitIBA
01/2016
1Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
09/2015
1Explosive Agents (Explosives)IBA
08/2014
1C-PeptideIBA
11/2013
1Antiviral Agents (Antivirals)IBA
02/2013
1Blocking AntibodiesIBA
02/2013
1Surface Antigens (Surface Antigen)IBA
07/2012
1Platelet Activating FactorIBA
01/2012
1GMA-161IBA
01/2012
1Opsonin Proteins (Opsonins)IBA
11/2011
1Fc Receptors (Fc Receptor)IBA
08/2011
1Insulin (Novolin)FDA Link
08/2011
1T-Cell Antigen Receptor-CD3 ComplexIBA
04/2011
1CD19 AntigensIBA
04/2011
1Trastuzumab (Herceptin)FDA Link
01/2011
1Immunoglobulin FragmentsIBA
06/2010
1Neutralizing AntibodiesIBA
04/2010
1IgG Receptors (Fc gamma RI)IBA
10/2009
1motavizumab (Numax)IBA
05/2007
1Fc gamma receptor IIBIBA
10/2006

Therapy/Procedure

12Therapeutics
09/2015 - 10/2006
3Immunotherapy
01/2018 - 09/2007
1Treatment Delay
06/2011
1Intravenous Infusions
06/2010